Apex Biotechnology Corp Strategic Asset Allocation Index
Apex Biotechnology Corp strategic asset allocation index. Apex Biotechnology Corp (1733) has a Strategic Asset Allocation Index of 42.7% as of June 2023. Strategic assets (PP&E of NT$743.92 Million plus long-term investments of NT$-) total NT$743.92 Million, measured against net assets of NT$1.74 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 1733 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Apex Biotechnology Corp (2002–2022)
Strategic asset allocation index of Apex Biotechnology Corp from 2002 to 2022. This chart shows how Apex Biotechnology Corp's Strategic Asset Allocation Index has evolved across 21 annual periods from 2002 to 2022. As of June 2023, the index stands at 42.7%, representing strategic assets of NT$743.92 Million against net assets of NT$1.74 Billion TWD.
Apex Biotechnology Corp Strategic Asset Allocation Index by Year (2002–2022)
Apex Biotechnology Corp strategic asset allocation index by year from 2002 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Apex Biotechnology Corp from 2002 to 2022, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Apex Biotechnology Corp market capitalisation.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 42.1% | NT$766.08 Million | NT$766.08 Million | NT$- | NT$1.82 Billion | ▼ -3.1 pp |
| 2021 | 45.3% | NT$794.12 Million | NT$794.12 Million | NT$- | NT$1.75 Billion | ▼ -5.0 pp |
| 2020 | 50.3% | NT$827.81 Million | NT$827.81 Million | NT$- | NT$1.65 Billion | ▼ -1.5 pp |
| 2019 | 51.8% | NT$868.46 Million | NT$862.26 Million | NT$6.20 Million | NT$1.68 Billion | ▲ +5.4 pp |
| 2018 | 46.4% | NT$762.53 Million | NT$762.50 Million | NT$40.00K | NT$1.64 Billion | ▼ -0.2 pp |
| 2017 | 46.6% | NT$776.00 Million | NT$761.87 Million | NT$14.13 Million | NT$1.66 Billion | ▼ -3.0 pp |
| 2016 | 49.7% | NT$860.23 Million | NT$832.89 Million | NT$27.35 Million | NT$1.73 Billion | ▼ -6.3 pp |
| 2015 | 56.0% | NT$1.08 Billion | NT$893.51 Million | NT$187.03 Million | NT$1.93 Billion | ▼ -7.0 pp |
| 2014 | 63.0% | NT$1.18 Billion | NT$978.20 Million | NT$197.03 Million | NT$1.87 Billion | ▼ -1.7 pp |
| 2013 | 64.6% | NT$1.24 Billion | NT$1.04 Billion | NT$197.03 Million | NT$1.92 Billion | ▲ +20.2 pp |
| 2012 | 44.4% | NT$893.74 Million | NT$893.74 Million | NT$- | NT$2.01 Billion | ▲ +11.9 pp |
| 2011 | 32.5% | NT$568.06 Million | NT$568.06 Million | NT$- | NT$1.75 Billion | ▼ -2.9 pp |
| 2010 | 35.4% | NT$576.27 Million | NT$576.27 Million | NT$- | NT$1.63 Billion | ▲ +1.3 pp |
| 2009 | 34.1% | NT$501.06 Million | NT$501.06 Million | NT$- | NT$1.47 Billion | ▼ -4.4 pp |
| 2008 | 38.4% | NT$485.97 Million | NT$485.97 Million | NT$- | NT$1.26 Billion | ▲ +12.4 pp |
| 2007 | 26.0% | NT$350.88 Million | NT$350.88 Million | NT$- | NT$1.35 Billion | ▼ -4.0 pp |
| 2006 | 30.0% | NT$330.95 Million | NT$330.95 Million | NT$- | NT$1.10 Billion | ▼ -6.8 pp |
| 2005 | 36.8% | NT$329.97 Million | NT$329.97 Million | NT$- | NT$896.93 Million | ▲ +9.7 pp |
| 2004 | 27.1% | NT$234.98 Million | NT$234.98 Million | NT$- | NT$865.91 Million | ▲ +11.1 pp |
| 2003 | 16.0% | NT$134.69 Million | NT$134.69 Million | NT$- | NT$842.42 Million | ▲ +4.4 pp |
| 2002 | 11.6% | NT$82.40 Million | NT$82.40 Million | NT$- | NT$712.76 Million | — |